Evidence map›Paper›PMID 41068923›Full record

ArticleMicrobial cell factories2025

Effects of bioreactor inoculation method on secondary metabolite production and morphological characteristics of Streptomyces rimosus in microparticle-enhanced cultivation (MPEC).

Anna Ścigaczewska, Tomasz Boruta, Marcin Bizukojć

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna ŚcigaczewskaDepartment of Bioprocess Engineering, Faculty of Process and Environmental Engineering, Lodz University of Technology, ul. Wólczańska 213, 93-005, Lodz, Poland. anna.kowalska.1@p.lodz.pl.ORCID http://orcid.org/0000-0003-4104-0263
Tomasz BorutaDepartment of Bioprocess Engineering, Faculty of Process and Environmental Engineering, Lodz University of Technology, ul. Wólczańska 213, 93-005, Lodz, Poland.
Marcin BizukojćDepartment of Bioprocess Engineering, Faculty of Process and Environmental Engineering, Lodz University of Technology, ul. Wólczańska 213, 93-005, Lodz, Poland.

Funding

National Science Centre (Republic of Poland) 2021/43/B/ST8/00268
6 · The paper itself

Abstract

Streptomyces rimosus is renowned for complex metabolic pathways and the ability to produce diverse bioactive secondary metabolites, including antibiotics, antifungals, and other biologically active compounds. Despite their industrial significance, the cultivation of filamentous microorganisms still remains a complex challenge. In this work, the production of secondary metabolites and morphological characteristics of Streptomyces rimosus were examined in microparticle-enhanced bioreactor cultivations (MPEC) initiated with either spore or preculture inocula. The addition of 10 μm talc microparticles in the concentrations equal to 2.5, 5, 7 and 10 g L−1 to S. rimosus cultivations conducted in the 5-litre stirred tank bioreactors markedly influenced the biosynthesis of secondary metabolites: oxytetracycline, decarboxamidooxytetracycline (ADOTC), rimocidin, rimocidin CE-108, rimocidin with 27 ethyl group, an unnamed angucycline, rimosamide A and rimosamide B. The example of rimocidin showed that the inoculation procedure was among the factors determining the efficiency of metabolite bioproduction in MPEC. In the spore-inoculated variant of the experiment, the addition of 7 g TALC L−1 enhanced rimocidin production 17-fold, while in the corresponding run inoculated with the preculture, microparticles had a negative effect or did not substantially enhance the biosynthesis of the metabolite. The presence of microparticles in S. rimosus cultivations reduced the projected area of agglomerates regardless of whether the bioreactor was inoculated with spores or preculture. In the spore-inoculated control run, the size of the largest agglomerates was equal to 2.1·104 µm2 (96 h, 0 g TALC L−1) while for the corresponding MPEC, it was equal to 1.1·104 µm2 (96 h, 10 g TALC L−1). At the end of the preculture-inoculated experiment, in the control run the agglomerates reached 1.0·105 µm2 (96 h, 0 g TALC L−1) and in the MPEC their sizes decreased below 3.5·104 µm2 (96 h, 5 g TALC L−1). The addition of microparticles induced various effects on the morphology number Mo of S. rimosus, dependent on the bioreactor inoculation procedure. In the preculture-inoculated runs with 7 and 10 g TALC L−1 the morphology number exceeded 0.50, which indicated the development of regular pellets. In the other cases, the agglomerates were irregular, with the range of morphology number from 0.22 to 0.48.

Indexed as

BioreactorsSecondary MetabolismStreptomycesStreptomyces rimosusSpores, BacterialTalcTalcBioreactors.InoculumMicroparticle-enhanced cultivationMorphological engineeringMorphologySecondary metabolitesStreptomyces

Identifiers

PMID41068923
PMCPMC12513026

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.